Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.

Implication of dopamine D3 receptor activation in the reversion of Parkinson's disease-related motivational deficits.

Carnicella S, Drui G, Boulet S, Carcenac C, Favier M, Duran T, Savasta M.

Transl Psychiatry. 2014 Jun 17;4:e401. doi: 10.1038/tp.2014.43.

PMID:
24937095
[PubMed - in process]
Free PMC Article
2.

Pramipexole reverses Parkinson's disease-related motivational deficits in rats.

Favier M, Duran T, Carcenac C, Drui G, Savasta M, Carnicella S.

Mov Disord. 2014 Jun;29(7):912-20. doi: 10.1002/mds.25837. Epub 2014 Feb 11.

PMID:
24515412
[PubMed - in process]
3.

High-frequency stimulation of the subthalamic nucleus modifies the expression of vesicular glutamate transporters in basal ganglia in a rat model of Parkinson's disease.

Favier M, Carcenac C, Drui G, Boulet S, El Mestikawy S, Savasta M.

BMC Neurosci. 2013 Dec 5;14:152. doi: 10.1186/1471-2202-14-152.

PMID:
24308494
[PubMed - indexed for MEDLINE]
Free Article
4.

Enhanced visual responses in the superior colliculus and subthalamic nucleus in an animal model of Parkinson's disease.

Rolland M, Carcenac C, Overton PG, Savasta M, Coizet V.

Neuroscience. 2013 Nov 12;252:277-88. doi: 10.1016/j.neuroscience.2013.07.047. Epub 2013 Jul 31.

PMID:
23916713
[PubMed - indexed for MEDLINE]
5.

Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease.

Drui G, Carnicella S, Carcenac C, Favier M, Bertrand A, Boulet S, Savasta M.

Mol Psychiatry. 2014 Mar;19(3):358-67. doi: 10.1038/mp.2013.3. Epub 2013 Feb 12.

PMID:
23399912
[PubMed - in process]
6.

Mitochondrial permeability transition pore inhibitors prevent ethanol-induced neuronal death in mice.

Lamarche F, Carcenac C, Gonthier B, Cottet-Rousselle C, Chauvin C, Barret L, Leverve X, Savasta M, Fontaine E.

Chem Res Toxicol. 2013 Jan 18;26(1):78-88. doi: 10.1021/tx300395w. Epub 2013 Jan 7.

PMID:
23268549
[PubMed - in process]
7.

Does MPTP intoxication in mice induce metabolite changes in the nucleus accumbens? A ¹H nuclear MRS study.

Chassain C, Bielicki G, Carcenac C, Ronsin AC, Renou JP, Savasta M, Durif F.

NMR Biomed. 2013 Mar;26(3):336-47. doi: 10.1002/nbm.2853. Epub 2012 Oct 12.

PMID:
23059905
[PubMed - indexed for MEDLINE]
8.

Discovering new bioactive neuropeptides in the striatum secretome using in vivo microdialysis and versatile proteomics.

Bernay B, Gaillard MC, Guryca V, Emadali A, Kuhn L, Bertrand A, Detraz I, Carcenac C, Savasta M, Brouillet E, Garin J, Elalouf JM.

Mol Cell Proteomics. 2009 May;8(5):946-58. doi: 10.1074/mcp.M800501-MCP200. Epub 2009 Jan 21.

PMID:
19164277
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Development of a sialic acid-containing hydrogel of poly[N-(2-hydroxypropyl) methacrylamide]: characterization and implantation study.

Woerly S, Fort S, Pignot-Paintrand I, Cottet C, Carcenac C, Savasta M.

Biomacromolecules. 2008 Sep;9(9):2329-37. doi: 10.1021/bm800234r. Epub 2008 Aug 21.

PMID:
18715030
[PubMed - indexed for MEDLINE]
10.

High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats.

Lacombe E, Carcenac C, Boulet S, Feuerstein C, Bertrand A, Poupard A, Savasta M.

Eur J Neurosci. 2007 Sep;26(6):1670-80. Epub 2007 Sep 6.

PMID:
17822436
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Subthalamic stimulation-induced forelimb dyskinesias are linked to an increase in glutamate levels in the substantia nigra pars reticulata.

Boulet S, Lacombe E, Carcenac C, Feuerstein C, Sgambato-Faure V, Poupard A, Savasta M.

J Neurosci. 2006 Oct 18;26(42):10768-76.

PMID:
17050715
[PubMed - indexed for MEDLINE]
Free Article
12.

Functional reinnervation from remaining DA terminals induced by GDNF lentivirus in a rat model of early Parkinson's disease.

Brizard M, Carcenac C, Bemelmans AP, Feuerstein C, Mallet J, Savasta M.

Neurobiol Dis. 2006 Jan;21(1):90-101. Epub 2005 Aug 9.

PMID:
16084732
[PubMed - indexed for MEDLINE]
13.

Pallidal origin of GABA release within the substantia nigra pars reticulata during high-frequency stimulation of the subthalamic nucleus.

Windels F, Carcenac C, Poupard A, Savasta M.

J Neurosci. 2005 May 18;25(20):5079-86.

PMID:
15901790
[PubMed - indexed for MEDLINE]
Free Article
14.

Neurochemical mechanisms induced by high frequency stimulation of the subthalamic nucleus: increase of extracellular striatal glutamate and GABA in normal and hemiparkinsonian rats.

Bruet N, Windels F, Carcenac C, Feuerstein C, Bertrand A, Poupard A, Savasta M.

J Neuropathol Exp Neurol. 2003 Dec;62(12):1228-40.

PMID:
14692699
[PubMed - indexed for MEDLINE]
15.

Hindlimb-suspension and spaceflight both alter cGMP levels in rat choroid plexus.

Carcenac C, Herbute S, Masseguin C, Mani-Ponset L, Maurel D, Briggs R, Guell A, Gabrion JB.

J Gravit Physiol. 1999 Oct;6(2):17-24.

PMID:
11543082
[PubMed - indexed for MEDLINE]
16.

Altered gravity downregulates aquaporin-1 protein expression in choroid plexus.

Masseguin C, Corcoran M, Carcenac C, Daunton NG, Güell A, Verkman AS, Gabrion J.

J Appl Physiol (1985). 2000 Mar;88(3):843-50.

PMID:
10710377
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk